找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊DRUGS IN R&D 2024/2025影响因子:2.237 (DRUGS R&D) (1174-5886). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index

[复制链接]
楼主: 近地点
发表于 2025-3-23 10:42:52 | 显示全部楼层
Submitted on: 29 June 1999. Revised on: 01 August 1999. Accepted on: 25 September 1999. ___________________DRUGS IN R&D---SPRINGER INT PUBL AG
发表于 2025-3-23 13:56:54 | 显示全部楼层
Submitted on: 09 December 1999. Revised on: 23 February 2000. Accepted on: 19 March 2000. ___________________DRUGS IN R&D---SPRINGER INT PUBL AG
发表于 2025-3-23 18:23:07 | 显示全部楼层
发表于 2025-3-24 00:53:14 | 显示全部楼层
Submitted on: 28 January 2024. Revised on: 30 March 2024. Accepted on: 25 April 2024. ___________________DRUGS IN R&D---SPRINGER INT PUBL AG
发表于 2025-3-24 05:18:12 | 显示全部楼层
Submitted on: 27 April 2004. Revised on: 03 August 2004. Accepted on: 25 August 2004. ___________________DRUGS IN R&D---SPRINGER INT PUBL AG
发表于 2025-3-24 10:29:14 | 显示全部楼层
Submitted on: 27 November 2011. Revised on: 05 February 2012. Accepted on: 01 April 2012. ___________________DRUGS IN R&D---SPRINGER INT PUBL AG
发表于 2025-3-24 11:35:13 | 显示全部楼层
Submitted on: 22 May 2009. Revised on: 14 July 2009. Accepted on: 12 September 2009. ___________________DRUGS IN R&D---SPRINGER INT PUBL AG
发表于 2025-3-24 16:27:38 | 显示全部楼层
Submitted on: 12 September 2013. Revised on: 26 November 2013. Accepted on: 02 January 2014. ___________________DRUGS IN R&D---SPRINGER INT PUBL AG
发表于 2025-3-24 22:07:34 | 显示全部楼层
Submitted on: 26 December 2018. Revised on: 05 March 2019. Accepted on: 04 May 2019. ___________________DRUGS IN R&D---SPRINGER INT PUBL AG
发表于 2025-3-24 23:50:50 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 20:33
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表